Accumulating data from epidemiologic studies are linking aspirin's use to a decline in chronic and metabolic inflammation that underlies many human diseases including some cancers. Aspirin reduces cyclooxygenase-mediated pro-inflammatory prostaglandins and promotes the production of pro-resolution molecules. Aspirin also triggers the production of anti-inflammatory electrophilic mono-oxygenated lipid mediators implicated in human pathologies. With the goal of developing a model system for studying the mechanisms of aspirin in reducing inflammation, we investigated aspirin's effects in fruit fly models of chronic inflammation. Ectopic Toll/NF-κB and JAK/STAT signaling in D. melanogaster results in an overproliferation of hematopoietic blood progenitors coupled with metabolic inflammation in adipocytes. We report that, like mammals, flies are sensitive to aspirin treatment and it modulates the Toll-NF-κB axis. Aspirin-treated mutants simultaneously experience reduction in metabolic inflammation, mitosis, ectopic immune signaling, and macrophage infiltration. Moreover, flies synthesize 13-HODE, and aspirin triggers 13-EFOX-L2 production in mutants. In such flies with ectopic immune signaling, providing 13-HODE's precursor linoleic acid or performing targeted knockdown of transcription factor STAT in inflammatory blood cells boosts 13-EFOX-L2 levels while decreasing metabolic inflammation. Thus, hematopoietic cells regulate metabolic inflammation in flies, and their effects can be reversed by pharmaceutical or dietary intervention, suggesting deep phylogenetic conservation in animals' ability to resolve systemic inflammation and repair tissue damage. This model system brings the power of Drosophila genetics to bear on immuno-metabolic mechanisms that boost systemic health and healing, with the potential to identify new targets for the treatment of chronic diseases in humans.
Introduction
As part of an animal's innate immune system, acute inflammation targets parasites and microbes and repairs injured tissues. Circulating macrophages and neutrophils migrate to sites of infection or injury where they initiate acute inflammation either to phagocytose and clear invading organisms, or to sequester parasite or cellular debris. Mammals and Drosophila rely on the archetypal pro-inflammatory NF-κB signaling pathway to activate the inflammation response (1) . Canonical NF-κB signaling employs Toll/Toll-like receptors (TLRs), which, when bound by pathogen-derived ligand in mammals, mediate the release (from their I-κB inhibitors) and nuclear import of NF-κB. NF-κB activates pro-inflammatory pattern of gene expression (1, 2) . Pathogen receptors in flies also activate Toll/NF-κB signaling for host defense (3) (4) (5) .
A key target of pro-inflammatory NF-κB activation in mammals that has garnered much attention is the prostaglandin-endoperoxide synthase 2/cyclooxygenase-2 (PTGS2/COX-2)
promoter (6) (7) (8) . COX-2 catalyzes the rate-limiting step in the conversion of the polyunsaturated C20:4 ω-6 fatty acid (FA), arachidonic acid (AA), to pro-/anti-inflammatory prostanoids (9) . AA, an important component of the plasma membrane's phospholipids, is derived from dietary omega-6 FA, linoleic acid (LA). Aspirin (acetylsalicylic acid, ASA) blocks the pro-inflammatory effects of prostanoids by acetylating and inhibiting COX-1 and -2 activities (10). NF-κB-mediated induction of COX-2 integrates eicosanoid-mediated signaling with NF-κB signaling. Toll/NF-κB signaling also responds to free fatty acid levels in the blood. For example, saturated (but not unsaturated) fatty acids activate TLR4 and its downstream mediators, and NF-κB p65 activation triggers COX-2 expression (11, 12) . Since Toll receptors sense both pathogens and nutrients in mammals, diet and energy balance are closely integrated with innate immunity and inflammation (2, 13, 14) .
A second biochemical effect of aspirin was identified in the resolution of acute inflammation, which occurs due to its ability to acetylate COX-2. Many studies have identified a new class of specialized pro-resolving mediators (SPMs) formed in the presence of acetylated COX-2. Derived from C20 or C22 ω-3 and ω-6 FAs, SPMs include lipoxins, resolvins, protectins, and maresins. SPMs boost efferocytosis, promote phagocytosis of microbes, and limit neutrophil-mediated tissue damage (15) . In human cell cultures, acetylated COX-2 also triggers the production of a family of electrophilic mono-oxygenated (EFOX) lipid mediators, including 17-and 13-EFOX, derived from ω-3 C22:6 docasahexanoic acid (DHA) (16) . While the existence and anti-inflammatory effects of EFOX in intact organisms have not been demonstrated yet, results of these cell culture studies point to the dual anti-inflammatory and pro-resolution roles of aspirin and suggest an explanation for how dietary supplementation of ω-3 FAs or aspirin stalls inflammation and supports well-being in humans (9, 16) . They also expose the diversity of eicosanoid and eicosanoid-like lipid mediators and the complexity of their cell-specific effects in maintaining normal organismic physiology. How are the pro-and anti-inflammatory effects of eicosanoid family members precisely integrated with metabolic and immune pathways in vivo? How are their effects unified from cellular to tissue and organ levels (e.g., from inflammatory blood cells to adipose tissue)? Because of their inherent diversity and cellular complexity, vertebrate models do not lend themselves to straightforward resolution of such questions.
To develop a simpler model for systematically addressing these issues, we used D.
melanogaster models with proven hallmarks of chronic inflammation (17) (18) (19) (20) . As in mammals, innate immunity in Drosophila also relies on NF-κB signaling (3) (4) (5) . Furthermore, systemic acute inflammation is induced by parasitic wasp infection. Injection of an egg into a fly larva activates inflammatory phagocytic macrophages (plasmatocytes) and their nonphagocytic derivatives (lamellocytes), which migrate and adhere to the wasp egg, blocking its development. This process relies on: (a) Spätzle (Spz), the pro-mitotic and pro-inflammatory cytokine and Toll ligand; (b) Spätzle Processing Enzyme (SPE); and (c) NF-κB transcription factors, Dorsal and Dif (18) . The canonical Toll/NF-κB target gene Drosomycin (Drs) is activated after wasp infection, as is cactus, the gene coding for the I-κB inhibitor of Dorsal/Dif (18) . In another parallel with mammalian immunity, the negative regulator Ubc9
(the E2 SUMO-conjugating enzyme) maintains immune homeostasis in Drosophila. As a consequence of persistent NF-κB signaling in cactus and Ubc9 mutants, small inflammatory blood tumors, made of macrophages and lamellocytes, appear in the larval body cavity.
Overexpression of SPE or Spz in blood cells of wild type animals induces similar tumors while reduction of spz lowers inflammation in Ubc9 mutants with concomitant reduction of tumors (18) .
Ubc9 mutants also exhibit significant loss of integrity in the basement membrane surrounding the liver-like fat body; collagen distribution is discontinuous and many macrophages infiltrate (i.e., adhere to) the diseased tissue. Wild type fat body is surrounded by a uniform and continuous deposit of collagen and has few, if any, macrophages adhering to it (18, 21) . Thus, akin to mammals, tissue damage in flies accompanies systemic inflammation (1, 2, 18, 22) .
Flies not only possess these conserved pro-inflammatory immune pathways for the activation of inflammation, but also react to metabolic stress in ways similar to humans. In response to a high-sugar diet (but not to excess dietary fat or protein), Drosophila develop signs of metabolic inflammation (or metainflammation) where cellular and molecular phenotypes resemble the pathophysiology of type-2 diabetes mellitus (2, 23) . High-sugar-fed larvae exhibit an altered metabolism and the cells of their fat body organ display larger-sized lipid droplets (LDs, which store and mobilize fat in animal cells (23) ). Therefore, mechanistically, sugar-induced metabolic dysregulation in flies resembles insulin resistance in humans (13, 21, 23) .
Given that flies exhibit hallmarks of parasite-induced inflammatory and diet-induced metainflammatory responses, we asked if these phenotypes are sensitive to aspirin, and if so, how aspirin might activate and coordinate animals' intrinsic healing mechanisms. While flies lack FAs longer than C18 (AA, DHA, etc.) (24) and eicosanoids have not been reported from Drosophila, prostaglandin administration rescues the loss-of-function of a human COX-1-like fly gene (25) , suggesting that flies possess primordial eicosanoid-based mechanisms through which aspirin might act. In addition, C20 polyunsaturated fatty acid (PUFA)-fed flies generate hydroxyeicosatetraenoic acid (13-HETE) (26) , an AA metabolite, suggesting that flies express enzymes for eicosanoid synthesis. Using computational methods, we recently showed that functional enzymes for eicosanoid biosynthesis are encoded in the fly genome.
This analysis revealed the existence of two other COX-like enzymes in addition to Pxt (27) .
We therefore hypothesized that inflammation readouts in flies may be sensitive to aspirin and flies might use simpler FA precursors to produce eicosanoid-like molecules.
Here we show aspirin's dose-dependent and molecular-, cell-, and organ-specific effects with striking parallels to its effects in mammals. We also show that flies produce 13-HODE, and aspirin increases its levels, while also triggering the production of its oxidized analog 13-oxo-ODE (called 13-EFOX-L2 here). These results demonstrate that members of the EFOX family of oxylipids are produced in intact organisms and their high levels correlate with a reduction in inflammation. Aspirin's efficacy in resolving inflammation and repairing tissue damage in fruit flies suggests genetic and biochemical conservation underlying these processes across the animal kingdom. Unbiased genetic screens in Drosophila that report the links between inflammation, diet, and drug action will have translational significance in identifying new therapies for inflammation-based human diseases.
Results
Wild type Canton S flies tolerate a wide range of orally administered aspirin. At 5 mM aspirin, 65% of the animals eclosed to adulthood while 42% of pupae became adults at 55 mM. In experiments described below, 0.5 nM to 1 mM aspirin was added to fly food (see SI for additional details). Aspirin uptake was confirmed by covalently conjugating it to Rhodamine B. Dissected hematopoietic and fat body cells did not retain the unconjugated dye ex vivo, but Rhodamine B-aspirin (Rh-ASA) localized to the perinuclear regions in both cell types (SI Fig. S1 ).
Aspirin inhibits hematopoietic overgrowth in Ubc9 mutants
We introduced 0. 
Aspirin restores regulation of Toll-NF-κB signaling in Ubc9 fat body
To examine if constitutive signaling in Ubc9 fat bodies (20) is rescued by aspirin, we studied Drs-GFP expression and noticed a significant decrease. At day 6, there was a ~40% decrease in the percentage of Drs-GFP positive larvae (0.5 nM ASA; Fig. 1G , H). Thus, it appears that as in mammalian cells (29) , aspirin inhibits chronic inflammation in flies by modulating the Toll-NF-κB axis. This decrease correlated with reduced infiltration of blood cells into the fat body adipocytes (Fig. 1I ).
Immune responses in mammals can modulate insulin signaling and nutrient storage (30) , and conversely, immune pathways are activated in response to nutrient stress (31) .
Given that the Toll/Dorsal pathway is constitutively active in Ubc9 fat bodies ( Fig. 1G-I ), we wondered if LD sizes are affected in mutants and if aspirin might reverse these effects. In flies, the diabetes-like metabolic state is reflected in larger LDs in larval fat bodies of animals consuming high dietary glucose (23) . Ubc9 fat bodies produce larger-than-normal LDs without additional glucose, and a slight increase is evident even in heterozygous cells compared to y w control ( Fig. S2A-C) . Aspirin treatment reverses this trend (Fig. S2D ) and the damaged mutant fat body morphologically appears intact when stained with RhPhalloidin ( Fig. 1I ; (18)). These results suggest that as in vertebrate models and in human trials where anti-inflammatory therapies restore metabolic function (31, 32) , aspirin treatment in flies also reduces metabolic stress.
Toll-NF-κB signaling is hyperactive in hopscotch
Tum-l blood cells; aspirin is anti-mitotic,
and improves organismal viability
To corroborate the effects of aspirin in another genetic background and understand how it promotes healing and tissue repair, we turned to the genetically uniform germline hopscotch Tum-l (hop Tum-l or simply Tum-l) mutant, where JAK-STAT signaling is hyperactive due to a dominant gain-of-function point mutation (19) . In these mutants, hyperactive STAT activity expands the hematopoietic progenitor population (17, 19, 33) and lymph gland dysplasia leads to tumor development and partial lethality (19, 34) (Fig. 2B-C S3A ). In contrast, we found that compared to the control y w outcross, hop Tum-l mutants were more viable when pro-inflammatory STAT or NF-κB signaling was knocked down. The most significant gains were seen with STAT, SPE, and spz knockdown in blood cells (Fig. 2E) . These results suggest a potential downstream (or cooperative) role of the SpzToll-Dorsal/Dif axis with STAT in hop Tum-l blood cells. Aspirin treatment (1 μM) of hop Tum-l animals reduced the mitotic index in circulating blood cells (SI Fig. S4A ). These results confirm that, as such, aspirin's effects are not limited to a specific genetic background, but instead its biological effects must be meditated by molecular pathways common to both mutants.
Like Ubc9 mutants, adipocytes of the hop Tum-l fat body form many large and distorted
LDs without added dietary glucose ( Fig. 2F; SI Fig. S4B ). The mutant fat body loses integrity and intercellular adhesion; several portions of the organ detach from the main organ (SI Fig.   S4C ). However, administration of 1 µM aspirin restored a significant portion of the small LD population and there were fewer large LDs ( Fig. 2F ; SI Fig. S4B) ; aspirin also restored the overall morphology of the organ (SI Fig. S4D ).
Encouraged by aspirin's strong and consistent anti-tumor and anti-inflammatory effects at the molecular, cellular, and organ levels in two inflammation models, we asked if these effects might translate to benefits at the organismic level and if aspirin improves viability of hop Tum-l animals. 1 nM and 1 μM aspirin improved the viability of hop Tum-l animals to adulthood (Fig. 2G ) and these gains paralleled viability increments in the targeted knockdown experiments (Fig. 2E ). This correlation suggested that aspirin's salutary effects are, in part, realized by blocking the systemic pro-inflammatory effects of blood cells. We hypothesized that, in addition to reducing mitosis and shrinking the pro-inflammatory blood cell population, aspirin might trigger oxylipid production whose anti-inflammatory effects may be realized in other parts of the body and possibly the entire organism. We tested this idea in biochemical experiments.
Discovery of 13-HODE and 13-EFOX-L2 in fly larvae
Because D. melanogaster lack FAs longer than C18 (24), we searched for non-classical antiinflammatory lipid mediators derived from unsaturated C18 precursors linoleic acid (LA) and alpha linolenic acid (ALA), present in the normal fly diet (24) . Oxidized derivatives of LA and ALA (13-hydroxyoctadecadienoic acid (13-HODE) and 13-hydroxyoctadecatrienoic acid (13-HOTrE), respectively; structures in Fig. 3A and SI Fig. S5A ) are bioactive and exert potent anti-inflammatory effects in mammals (9, 15, 16, 32, 35) . In LC-MS/MS-based targeted lipidomics of larval extracts, we did not detect 13-HOTrE in wild type or mutant larvae, but discovered that untreated third instar wild type and hop Tum-l larvae produce 13-HODE at levels comparable to mammalian cells (~40 nM (Fig. 3B; Fig. S5B, D) (36) ). Application of an enantiomer-specific antibody in ELISA experiments (Enzo Life Sciences) confirmed the presence of 13(S)-HODE in both isolated larval fat bodies and remaining organs of untreated larvae suggesting its wide occurence in the body. Chiral LC-MS/MS analysis resolved the R and S enantiomers of 13-HODE and showed that 13(S)-HODE was twice as abundant as 13(R)-HODE regardless of genetic background or aspirin treatment (SI Fig. S5D ). This enantiomeric imbalance indicates that at least some of the oxidation product may be generated enzymatically. In mammalian models, the R and S enantiomers demonstrate pro-or anti-inflammatory activities.
Quantitative LC-MS/MS further revealed that 13-HODE levels increase 3-fold in y w and hop Tum-l larvae upon treatment with 1 μM and 1 mM aspirin (Fig. 3B) . At 1 nM aspirin, however, a comparable 3-fold increase is observed only in the hop Tum-l mutants but not in wild type animals (Fig. 3B) , suggesting different response thresholds in these genetic backgrounds.
13-EFOX-L2 levels rise in response to aspirin and linoleic acid supplement
The hydroxyl group in 13-HODE, responsible for its chiral nature, can be further oxidized to generate the corresponding electrophilic derivative 13-EFOX-L2 according to the mechanism proposed by Groeger et al. for other PUFAs (9) (Fig. 3A) . We detected 13-EFOX-L2 in only hop Tum-l mutants at high aspirin concentrations (1 μM and 1 mM) but not in control y w animals ( Fig. 3C; SI Fig. S5C ). Appearance of 13-EFOX-L2 correlate with the rise in 13-HODE in response to aspirin treatment of mutants (Fig. 3B) , supporting the idea that 13-HODE is a substrate for 13-EFOX-L2 synthesis in vivo (Fig. 3A) .
The discovery of 13-HODE and 13-EFOX-L2, two LA-derived oxylipids in larval extracts prompted us to examine whether hop Tum-l mutants would benefit from dietary addition of LA (13-HODE and 13-EFOX-L2 are chemically unstable for such experiments). 5 mM LA treatment increased hop Tum-l 's larval-to-adult viability from 35% to up to 90% (SI Fig. S5E ) while 5 mM myristic acid addition had almost no effect (SI Fig. S5E ; unlike LA, MA is a fully saturated C18 FA).
Unlike 1 μM and 1 mM aspirin, 5 mM LA treatment did not yield a significant increase in 13-HODE (Fig. 3B ), but 13-EFOX-L2 was clearly detected in LA-treated y w animals and it was 7-fold higher in LA-treated hop Tum-l mutants than their asprin-treated counterparts (Fig. 3C ). These correlations suggest that (a) the double unsaturations in LA are essential for its biochemical transformation to 13-EFOX-L2, (b) 13-HODE and 13-EFOX-L2 levels can be modulated by dietary modification in the absence of aspirin, and (c) aspirin's and LA's effects in vivo are realized differently. Overall, however, 13-HODE and 13-EFOX-L2 appear to reduce inflammation and improve the survival of hop Tum-l mutants. We did not detect other members of the EFOX-D or -E families identified in mammalian cells (9), perhaps because they derive from C20 precursors not found in flies (24) . (Fig. 4A) , and this reduction may be due, in part, to reduced mitosis in msn>STAT RNAi macrophages (Fig. 4B) . The msn promoter is active in many lymph gland progenitors as early as 56 hours (second larval instar (40) (Fig. 4E, F) . The levels of these oxylipids remained unchanged with control RNAi (SI Fig. S3D , E). These in vivo 13-HODE and 13-EFOX-L2 levels are consistent with corresponding measurements in mammalian cells (9, 36) . Together, our observations suggest that a STAT-dependent pro-inflammatory signal from hematopoietic cells affects immune and metabolic health of flies by regulating 13-HODE and 13-EFOX-L2 levels.
A blood cell-derived signal affects metainflammation and EFOX levels in drug-free

Discussion
Basic science and clinical discoveries have revealed the pervasive role of inflammation in human disease. Many of these studies expose the intimate links between diet, drugs, and disease development (2, (13) (14) (15) . Our studies of aspirin's effects in fruit flies show that aspirin treatment reduces pro-inflammatory cytokine-producing cells and metabolic inflammation.
These changes correlate with an increase in anti-inflammatory oxylipids.
Aspirin's anti-mitotic effects appear to be important to its salutary effects in flies. In both Ubc9 and hop Tum-l flies, spz expression is high (18, 34) and selective knockdown of spz in (untreated) and 60.7 ± 23% (0.5 nM aspirin-treated) larvae were GFP-positive. The number of 6-day old larvae per replicate ranged from 8 to 19; the number of 8-day old larvae used per replicate ranged from 5 to 18 (few 8-day old animals survive). p = 0.03 for 6-day old larvae; p = 0.12 in 8-day old larvae; student t-test was applied.
Materials and Methods
Fly lines
(I) Drs-GFP fat bodies from untreated (left) and aspirin-treated (right) 8-day-old Ubc9 larvae show simultaneous reduction in blood cell infiltration (Rhodamine-Phalloidin; arrows) and GFP expression. (Scale bar: 50 μm).
Fig. 2. Aspirin is anti-inflammatory in hop
Tum-l larvae and improves viability. LD sizes are quantified in SI Fig. S4B .
(G) Larval-to-adult viability of hop Tum-l msn>mCD8-GFP animals upon systemic aspirin treatment (mean ± standard deviation is shown across four biological replicates; n > 38 larvae per replicate; ** p < 0.05; student t-test). 
